Table of Contents Author Guidelines Submit a Manuscript
Malaria Research and Treatment
Volume 2014, Article ID 263674, 20 pages
Review Article

Does the Use of Dihydroartemisinin-Piperaquine in Treating Patients with Uncomplicated falciparum Malaria Reduce the Risk for Recurrent New falciparum Infection More Than Artemether-Lumefantrine?

1AngloGold Ashanti Hospital, P.O. Box 10, Obuasi, Ghana
2Florence Nightingale School of Nursing and Midwifery, King’s College London, London SE1 8WA, UK

Received 8 February 2014; Revised 4 May 2014; Accepted 18 May 2014; Published 19 June 2014

Academic Editor: Donatella Taramelli

Copyright © 2014 Wisdom Akpaloo and Edward Purssell. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [2 citations]

The following is the list of published articles that have cited the current article.

  • Laura Zehnacker, Marie-Claire Nevers, Veronique Sinou, Dominique Parzy, Christophe Creminon, Daniel Parzy, and Stephane Azoulay, “Development of sensitive direct chemiluminescent enzyme immunoassay for the determination of dihydroartemisinin in plasma,” Analytical And Bioanalytical Chemistry, vol. 407, no. 25, pp. 7823–7830, 2015. View at Publisher · View at Google Scholar
  • Amani Thomas Mori, Ole Frithjof Norheim, and Bjarne Robberstad, “Budget Impact Analysis of Using Dihydroartemisinin-Piperaquine to Treat Uncomplicated Malaria in Children in Tanzania,” Pharmacoeconomics, vol. 34, no. 3, pp. 303–314, 2016. View at Publisher · View at Google Scholar